To determine whether an ongoing response to Leishmania major would affect the response to a non-crossreacting, non-leishmanial antigen, susceptible BALB/c mice and resistant C3H mice were infected with L. major parasites expressing Escherichia coli ␤-galactosidase (␤-GAL); this parasite was designated L. major-␤GAL. BALB/c and C3H mice responded to infection with L. major-␤GAL by mounting a CD4 T-cell response to both parasite antigens and to the reporter antigen, ␤-GAL. The phenotypes of these T cells were characterized after generating T-cell lines from infected mice. As expected, BALB/c mice responded to infection with L. major-␤GAL by producing interleukin 4 in response to the parasite and C3H mice produced gamma interferon (IFN-␥) in response to the parasite and ␤-GAL. Interestingly, however, BALB/c mice produced IFN-␥ in response to ␤-GAL. Taken together, these results demonstrate that priming of IFN-␥-producing cells can occur in BALB/c mice despite the fact the animals are simultaneously mounting a potent Th2 response to L. major.
The two major subsets of the CD4 T-cell compartment of mice, Th1 and Th2, produce distinct repertoires of cytokines.
For example, Th1 cells secrete gamma interferon (IFN-␥) and interleukin 2 (IL-2) while Th2 cells secrete IL-4 and IL-5 (23).
The functions of Th1 and Th2 cells are modulated by the reciprocal cross-regulatory properties of these cytokines. Moreover, other cells of the immune system, such as macrophages (Ms), produce cytokines (e.g., IL-10, IL-12, and transforming growth factor ␤) that can influence the activities of T cells. Infection of mice with Leishmania major is perhaps the best-studied example of a disease in which selective activation of Th cells leads to opposite outcomes of infection. Most mouse strains (e.g., C57BL/6 and C3H) mount a Th1 response to the parasite and cure the infection, whereas susceptible mice (e.g., BALB/c) mount a Th2 response and succumb to infection (4, 20, 24, 25, 32) .
These observations point to an interesting question regarding immunoregulation. How might a heavily skewed Th1 or Th2 parasite-specific response influence the concomitant response of T cells to a protein that was antigenically unrelated to Leishmania?
To address this question, we utilized techniques developed for introducing and expressing foreign genes in L. major (7) . Using this approach, we expressed a bacterial antigen, namely Escherichia coli ␤-galactosidase (␤-GAL), in L. major and then infected mice with this transfected parasite, which was designated L. major-␤-GAL. Since the expressed ␤-GAL would be targeted to the same phagolysosome as L. major and be exposed to the same set of phagolysosomal degradative enzymes, it could serve as a "reporter antigen" to determine how a Th1 or Th2 response to L. major influences the immune response to ␤-GAL. Therefore, we followed the T-cell response to both L. major and ␤-GAL in mice infected with L. major-␤GAL. We anticipated that the response to ␤-GAL would be type 1 in mice mounting a Th1 response to L. major, whereas it would be type 2 in mice mounting a Th2 response to the parasite.
MATERIALS AND METHODS
Parasites. L. major promastigotes (LV39/Neal/P strain, clone 5 [22] ) were maintained in M199 or NNN medium as previously described (8, 22) . For experiments, promastigotes were harvested from stationary phase cultures which contained the infective (metacyclic) form of the parasite (26) . To produce amastigotes, promastigotes were injected subcutaneously (s.c.) into the shaved rumps of BALB/c mice or BALB/c nu/nu mice, and amastigotes were isolated according to published techniques (11) .
Molecular constructs and transfection. To express ␤-GAL within L. major, we used the vector pXG (strain B1288 [12] ). The E. coli lacZ coding region was introduced into the pXG expression site, yielding the plasmid pXG-␤GAL (strain B1007; L. Borges and S. M. Beverley, unpublished data). Parasites freshly recovered from infected mice were transfected with pXG-NEO or pXG-␤GAL by electroporation, and clonal lines were obtained by plating on semisolid media as previously described (15) . Transfected promastigotes were maintained in medium containing 10 g of Geneticin (Sigma, St. Louis, Mo.) per ml. Several transfectants were inoculated into mice to confirm that they remained infective, and one each bearing one or the other plasmid and showing wild-type infectivity was identified and used in this work. Infective L. major promastigotes containing pXG-NEO were designated L. major-NEO while those containing pXG-␤GAL were designated L. major-␤GAL.
Determining ␤-GAL activity. Pellets containing 2.5 ϫ 10 7 parasites (promastigotes or amastigotes) were snap frozen in liquid nitrogen and then resuspended in 100 l of TPI buffer (19) containing 0.01% sodium dodecyl sulfate (SDS). ␤-GAL activity was determined as previously described (19) , taking care to ensure that the amount of extract and the time of the assay were in the linear range of the assay. Extract aliquots were diluted to 80 l with TPI and added to 320 l of reaction buffer containing 0.3 mM 4-methyl-umbelliferyl ␤-D-galactoside (Sigma). Aliquots of 40 l were taken at 10-min intervals and added to 200 l of stop buffer. The fluorescence of the 4-methylumbelliferone (4-MU) product was measured in a Bio-Rad Fluoromark microplate fluorometer and compared to that of known concentrations of 4-MU (Sigma). In these assays, 2,700 fluorescence units corresponds to 1 nmol of 4-MU product. Assays of purified E. coli ␤-GAL (Sigma) showed a specific activity of 1. (5, 6, 30) .
Generating antigen-specific T-cell blasts and flow cytometry. The LNC (5 ϫ 10 6 /ml) draining lesions on infected mice were cultured in 24-well flat-bottom plates (Costar) and stimulated with L. major (5 ϫ 10 5 /ml) promastigotes or ␤-GAL (100 g/ml). The blast cells were isolated on Percoll gradients (29) .
Methods used to analyze the cell surface phenotype of murine lymphocytes are described elsewhere (6, 30) .
Activating ␤-GAL-specific T-cell hybridoma 1E3.03.H4 to produce IL-2. The T-cell hybridoma 1E3.03.H4 (kindly provided by J. Langhorne, Imperial College, London, England, and I. Muller, University of Notre Dame, Notre Dame, Ind.) is I-A d restricted and ␤-GAL specific. As a result, it produces IL-2 when activated by BALB/c Ms presenting ␤-GAL (10). 1E3.03.H4 was maintained in DMEM containing 5% fetal calf serum.
To stimulate 1E3.03.H4, BALB/c starch-elicited peritoneal exudate cells (31) were cultured (DMEM plus 5% fetal calf serum) in 24-well plates (10 6 cells/well, 1 ml of total volume) overnight at 37°C. The wells were rinsed with warm DMEM to remove nonadherent cells. The remaining adherent cells (consisting of 95% Ms [5] ) were cultured for an additional 4 h with either medium alone or 100 U of IFN-␥ (13) plus 10 ng of lipopolysaccharide (LPS)/ml (E. coli 055:B55W; Difco, Detroit, Mich.) (10 ng of LPS/ml is a subactivating dose [28] ). Cultures were rinsed, and Ms were cultured for another 4 h at 34°C with either ␤-GAL (50 g/ml) or various forms of L. major (see text for details). Finally, the cultures were rinsed, 1E3.03.H4 cells were added (10 6 cells/well), and the cultures were incubated for 18 h. The supernatants of the cultures were collected and analyzed for their content of IL-2 by capture enzyme-linked immunosorbent assay using published techniques (5, 6, 30) as an indicator of the degree of activation of 1E3.03.H4.
RESULTS
Generating L. major expressing high levels of ␤-GAL throughout the infectious cycle. We chose ␤-GAL as our reporter antigen since, when emulsified in complete Freund's adjuvant and injected into mice, ␤-GAL elicits a potent type 1 response (data not shown).
In previous studies, we utilized the pX expression vector to express high levels of ␤-GAL in L. major and Leishmania mexicana (18, 21) . However, subsequent data suggested that ␤-GAL expression was down-regulated in lesion amastigotes (21; L. Borges and S. M. Beverley, unpublished data). In this work, we used a related expression vector, pXG-NEO, which yields consistently higher expression in the amastigote stage (L. Borges and S. M. Beverley, unpublished data).
We introduced pXG-NEO and pXG-␤GAL into L. major promastigotes and identified infective clonal transfectants bearing a plasmid. Those bearing pXG-NEO were designated L. major-NEO while those containing pXG-␤GAL were designated L. major-␤GAL. L. major-␤GAL promastigotes expressed high levels of ␤-GAL, 46 ng/10 6 cells (about 2% of the total cell protein). The ␤-GAL in these L. major-␤GAL parasites was exclusively intracellular, as revealed by the absence of staining of colonies by the sensitive chromogenic substrate X-Gal (5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside; data not shown).
To confirm that the production of ␤-GAL remained high in the amastigote form of L. major, L. major-␤GAL amastigotes were purified from cutaneous lesions of BALB/c mice 3 weeks after infection. These amastigotes showed high levels of ␤-GAL, 10 ng/10 6 cells, or about 22% of the level present in promastigotes when they were injected into mice. Preliminary studies suggest that the majority of the decrease relative to the levels in promastigotes arose from a decline in the episomal pXG-␤GAL plasmid copy number during the period of growth in vivo, rather than specific developmental regulation of pXG-␤GAL expression (data not shown). Thus, L. major-␤GAL showed a sustained ability to express ␤-GAL throughout the parasite infectious cycle in mice infected with the parasite. As a result, L. major-␤GAL was an ideal candidate for the experiments presented here.
L. major-NEO induces only a leishmanial-specific response, but L. major-␤GAL induces both a leishmanial and ␤-GALspecific response in BALB/c and C3H mice. We chose to use BALB/c or C3H mice as our experimental model since they represent mice that are highly susceptible or highly resistant to infection with L. major, respectively (2, 27) . These mice were FIG. 1. L. major-NEO induces only a leishmanial-specific response in BALB/c and C3H mice. BALB/c mice (A) and C3H mice (B) were injected with 2.5 ϫ 10 6 L. major-NEO amastigotes s.c. in one hind footpad. At the indicated times thereafter, the draining LNC were plated at the rate of 4 ϫ 10 5 per well. The LNC were stimulated with L. major (10 6 /ml) or ␤-GAL (100 g/ml). The degree of proliferation was assessed by scintillation counting; see Materials and Methods for detailed techniques. Results are from triplicate wells (means Ϯ standard deviations) and are representative of three independent experiments. ‫,ء‬ no proliferation detected. infected with either 2.5 ϫ 10 6 amastigotes of control parasites (L. major-NEO) or L. major-␤GAL s.c. in one hind footpad. At various times thereafter, the draining LNC were removed and restimulated in vitro with either L. major or ␤-GAL. As determined in vitro, BALB/c and C3H mice responded to infection with L. major-NEO by generating a vigorous parasite-specific response, but little or no response to ␤-GAL (Fig. 1 ). In contrast, BALB/c and C3H mice responded to both L. major and ␤-GAL in vitro following infection with L. major-␤GAL. At 3 weeks of infection, the ␤-GAL-specific response was approximately 40% of the response to the parasite (Fig. 2) .
It should be noted that amastigotes were utilized for the experiments presented here since very few amastigotes, relative to promastigotes, are lysed when they are injected into mice (14) . This approach minimized the possibility that ␤-GAL released from lysing L. major-␤GAL promastigotes at the inception of the infection might have influenced our results. However, to directly test this possibility, 2.5 ϫ 10 6 L. major-NEO control parasites were purposely contaminated with soluble ␤-GAL (100 g), and these were coinjected s.c. into the footpads of BALB/c and C3H mice. At varying times thereafter, the draining LNC were removed and restimulated in vitro with either L. major or ␤-GAL. Importantly, this approach did not prime BALB/c mice to ␤-GAL and produced only a shortlived response to ␤-GAL in C3H mice (Fig. 3) .
␤-GAL induces IFN-␥ production in BALB/c mice. Next, we determined the cytokines secreted by LNC harvested from BALB/c mice infected with L. major-␤GAL. Figure 4 shows that LNC from BALB/c mice responded to parasite antigens in the anticipated fashion; namely, they produced a substantial amount of IL-4 and little IFN-␥. In contrast, these LNC produced predominantly IFN-␥ and little IL-4 when restimulated with ␤-GAL in vitro. Therefore, (i) ␤-GAL-specific cells were primed in BALB/c mice infected with L. major-␤GAL, (ii) these cells proliferated to ␤-GAL stimulation in vitro, and (iii) these cells made IFN-␥ when stimulated with ␤-GAL.
In C3H mice infected with L. major-␤GAL, IFN-␥ was produced in response to both leishmanial antigens and to ␤-GAL, whereas little or no IL-4 was produced in response to either antigen (Fig. 4) .
L. major-␤GAL primes CD4 L. major-and ␤-GAL-specific T cells. Since the production of IFN-␥ in response to ␤-GAL was not the result expected from the BALB/c mice, we wished to characterize this response further. The principal cell that responds to infection with L. major in mice is a CD4 T cell (4, 20, FIG. 2. L. major-␤GAL induces both a leishmanial-and ␤-GAL-specific response in BALB/c and C3H mice. BALB/c mice (A) and C3H mice (B) were infected with 2.5 ϫ 10 6 L. major-␤GAL amastigotes, and the draining LNC were treated as described in the legend of Fig. 1 . Results are representative of three independent experiments.
FIG. 3. Injecting L. major-NEO plus ␤-GAL does not prime BALB/c mice to
␤-GAL and induces a short-lived response to ␤-GAL in C3H mice. BALB/c mice (A) and C3H mice (B) were injected with 2.5 ϫ 10 6 L. major-NEO amastigotes plus 100 g of ␤-GAL. At the indicated times thereafter, draining LNC were restimulated as described in the legend of Fig. 1 . Results are representative of two independent experiments. ‫,ء‬ no proliferation detected. 24, 25, 32) . Therefore, we determined whether the cells responding in our system were CD4 T cells. LNC draining the site of infection with L. major-␤GAL were stimulated for 5 days in vitro with either L. major or ␤-GAL, and the responding T-cell blasts were isolated. Fluorescence-activated cell sorting analysis (Table 1) revealed that the surface phenotype of the cells that responded to either L. major or ␤-GAL was largely that of CD4 T cells. However, some cells were CD8 (12 to 15%). Thus, it is likely that CD4 cells, and perhaps CD8 cells, were the source of the IFN-␥ shown in Fig. 4 .
L. major-␤GAL-infected Ms do not activate ␤-GAL-specific T cells unless the Ms are activated with IFN-␥ plus LPS.
Taken as a whole, the data presented show that when L. major is transfected with the Th1 antigen ␤-GAL, the transfected parasite (L. major-␤GAL) induces a T-cell response to itself and to ␤-GAL in BALB/c mice (Fig. 2) . Moreover, this ␤-GAL priming appears to occur only after L. major-␤GAL is internalized by phagocytic cells (e.g., Ms) which then present ␤-GAL to responding T cells. The latter conclusion is supported by the data of Fig. 2 and 3 , wherein it is shown (i) that L. major purposely contaminated with soluble ␤-GAL does not induce a ␤-GAL response in BALB/c mice (therefore, possible early extracellular lysis of injected L. major-␤GAL parasites with the release of ␤-GAL was not responsible for the ␤-GAL response observed [ Fig. 3] ) and (ii) that the response to ␤-GAL in L. major-␤GAL-infected BALB/c mice was greatest at 3 weeks of infection (Fig. 2) -a time by which L. major-␤GAL has presumably long since been internalized by phagocytes in the mice.
To directly test whether L. major-␤GAL-infected BALB/c Ms could present ␤-GAL to ␤-GAL-specific T cells, we infected BALB/c Ms in vitro with the parasite and tested whether these Ms could activate the I-A d -restricted, IL-2-producing ␤-GAL-specific T cell hybridoma, 1E3.03.H4. Following incubation with soluble ␤-GAL, starch-elicited peritoneal BALB/c Ms induced a marked IL-2 response from 1E3.03.H4 (Fig. 5) . In contrast, following infection with L. major-␤GAL, BALB/c Ms were unable to present ␤-GAL unless the cells were activated with IFN-␥ plus LPS (Fig. 5) . This was a dose-dependent response, in that the greater the degree of infection with L. major-␤GAL, the greater was the IL-2 signal secreted by 1E3.03.H4 (Fig. 5) . response was specific for ␤-GAL since no IL-2 was secreted when BALB/c Ms were infected with L. major-NEO and activated with IFN-␥ plus LPS (Fig. 5) .
DISCUSSION
We used an L. major parasite that expresses a non-leishmanial reporter Th1 antigen (␤-GAL) to determine how the response to this reporter antigen is affected by a simultaneous response to L. major. L. major is known to induce strongly polarized Th1 or Th2 responses in resistant or susceptible mouse strains, respectively (reviewed in references 4, 20, 24, 25, 32) . Our results suggest that (i) ␤-GAL-specific T cells were primed in susceptible BALB/c mice following infection with L. major-␤GAL (Fig. 2) , (ii) these cells were not primed by soluble ␤-GAL released from L. major-␤GAL that were lysed when injected into mice (Fig. 3 ) (although this does not exclude the possibility that later in infection, soluble ␤-GAL would be released from phagocytic cells degrading L. major-␤GAL), and (iii) ␤-GAL-specific T cells were capable of secreting large quantities of IFN-␥ when restimulated with ␤-GAL in vitro (Fig. 4) .
It is interesting that BALB/c Ms were able to present ␤-GAL to responding T cells in vitro following infection with L. major-␤GAL and activation with IFN-␥ plus LPS (Fig. 5) . This suggests that Ms in BALB/c mice also present ␤-GAL in vivo when the cells become infected with L. major-␤GAL. The data of Fig. 5 also suggest that efficient presentation of ␤-GAL does not occur unless BALB/c Ms are activated. The reason activation is required is unknown. Since the location of ␤-GAL in L. major-␤GAL parasites is exclusively intracellular, some destruction of L. major-␤GAL by BALB/c Ms (by, for example, activation with IFN-␥) may be required before the cells can effectively present ␤-GAL. Taken as a whole, these observations suggest that priming of ␤-GAL-specific T cells would not occur in BALB/c mice infected with L. major-␤GAL unless antigen-presenting cells in the animals are activated to kill L. major-␤GAL, thus releasing ␤-GAL for antigen processing and presentation. The literature supports this contention. Although there is rapid multiplication of L. major in the first week of infection in both resistant and susceptible mice, the rate of multiplication of the parasite in BALB/c mice slows considerably beyond the second week of infection (34) , and the second week of infection is the time by which ␤-GAL-specific T cells could be recovered from BALB/c mice ( Fig. 2 and 4) . Moreover, treating BALB/c mice with a neutralizing anti-IFN-␥ antibody worsens an infection with L. major and results in rapid dissemination of the parasite in BALB/c mice, which suggests that IFN-␥ activates cells infected with L. major to kill the parasite in vivo (3). Finally, work by Wolfram et al. (35) directly demonstrated that Ms were unable to present amastigote cysteine proteinase antigens of L. mexicana to T cells unless the Ms were activated to kill the parasite intracellularly.
Other investigators have examined whether an ongoing Th2-skewed immune response can influence the immune response to an unrelated antigen. For example, Kullberg et al. (17) showed that the response to sperm whale myoglobin was more Th2-like in mice infected with Schistosoma mansoni as compared to that in uninfected control mice. In addition, BarralNetto et al. (1) and Doherty et al. (9) showed that an ongoing Th2-biased response in mice exacerbated infection with either Leishmania amazonensis or L. major, respectively. Curiously, Doherty et al. (9) showed that even though infection with L. major was exacerbated, the mice still produced Th1 cytokines when lymphoid tissue was restimulated with leishmanial antigens in vitro. This result is in agreement with the results presented here (Fig. 4) .
Genetically engineered Leishmania organisms have been used by others to study antigen processing in Ms infected with L. major (16) and to study the importance of cytotoxic T lymphocytes in the resistance of mice to infection with L. mexicana (21) . In this study, we used these transfection systems to express ␤-GAL in L. major. We then used the resulting parasite (L. major-␤GAL) to study immunoregulation in mice infected with L. major-␤GAL. The advantage of this approach is that it allows one to study the effect of L. major infection on an unrelated antigen (␤-GAL) without having to coinfect mice with another pathogen. Compared to the L. major-␤GAL system, coinfecting mice with two pathogens introduces unnecessary complications which might confound the interpretation of results. A second advantage of the L. major-␤GAL system is that since ␤-GAL is exclusively intracellular in L. major-␤GAL, L. major and its reporter antigen, ␤-GAL, should be targeted to the same phagolysosome of phagocytic cells in mice infected with L. major-␤GAL. Therefore, the ability to genetically manipulate Leishmania offers a powerful tool to address matters as diverse as mechanisms of immunoregulation in mice infected with the parasite to the development of auxotrophic gene knockout parasites that can be used as a platform for the development of safe live vaccines for leishmaniasis (33) .
